Elrakaybi, A.; Ruess, D.A.; Lübbert, M.; Quante, M.; Becker, H.
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers 2022, 14, 5926.
https://doi.org/10.3390/cancers14235926
AMA Style
Elrakaybi A, Ruess DA, Lübbert M, Quante M, Becker H.
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers. 2022; 14(23):5926.
https://doi.org/10.3390/cancers14235926
Chicago/Turabian Style
Elrakaybi, Asmaa, Dietrich A. Ruess, Michael Lübbert, Michael Quante, and Heiko Becker.
2022. "Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment" Cancers 14, no. 23: 5926.
https://doi.org/10.3390/cancers14235926
APA Style
Elrakaybi, A., Ruess, D. A., Lübbert, M., Quante, M., & Becker, H.
(2022). Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers, 14(23), 5926.
https://doi.org/10.3390/cancers14235926